David Einstein
Academic Medical Oncologist Specializing in Genitourinary Cancers · Beth Israel Deaconess Medical Center
Credentials: · · ·
History
Research
Nature Cancer · 2021 · 220 citations
Journal of Clinical Oncology · 2022 · 88 citations
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
JCO Precision Oncology · 2019 · 81 citations
19 papers
- CC
9 papers · 8 as a resident
9 papers
- HY
9 papers
8 papers
- JR
7 papers · 1 as a resident
6 papers
6 papers
Grants
- 2003–2031
National Cancer Institute · P50
Project lead · $322.2K · Beth Israel Deaconess Medical Center
Clinical trials
- 2023–2026
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Principal investigator · Active not recruiting · Early phase 1
Beth Israel Deaconess Medical Center
- 2021
Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer
Principal investigator · Withdrawn · Phase 2
Beth Israel Deaconess Medical Center
- 2018–2026
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
Beth Israel Deaconess Medical Center
- 2026–2029
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute